Zheng, Difan <br/><br/>
Prevalence and Clinicopathological Characteristics of BRAF Mutations in Chinese Patients with Lung Adenocarcinoma.  [electronic resource] 

 -  Annals of surgical oncology  Dec 2015 
 - S1284-91 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1534-4681 
<br/><br/><label>Standard No.: </label>10.1245/s10434-015-4640-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma, Mucinous--drug therapy<br/>Adenocarcinoma, Papillary--drug therapy<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Asian People--genetics<br/>Biomarkers, Tumor--genetics<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Mutation--genetics<br/>Neoplasm Invasiveness<br/>Neoplasm Recurrence, Local--drug therapy<br/>Neoplasm Staging<br/>Prevalence<br/>Prognosis<br/>Proto-Oncogene Proteins B-raf--genetics<br/>RNA, Messenger--genetics<br/>Real-Time Polymerase Chain Reaction<br/>Retrospective Studies<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Survival Rate<br/>Young Adult